97 related articles for article (PubMed ID: 19443568)
1. Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.
Chergui F; Chrétien AS; Bouali S; Ramacci C; Rouyer M; Bastogne T; Genin P; Leroux A; Merlin JL
Clin Chem; 2009 Jul; 55(7):1327-36. PubMed ID: 19443568
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
3. 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis.
Rojo F; Najera L; Lirola J; Jiménez J; Guzmán M; Sabadell MD; Baselga J; Ramon y Cajal S
Clin Cancer Res; 2007 Jan; 13(1):81-9. PubMed ID: 17200342
[TBL] [Abstract][Full Text] [Related]
4. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.
Bacus SS; Chin D; Yarden Y; Zelnick CR; Stern DF
Am J Pathol; 1996 Feb; 148(2):549-58. PubMed ID: 8579117
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.
Merlin JL; Harlé A; Lion M; Ramacci C; Leroux A
Oncol Rep; 2013 Oct; 30(4):1943-8. PubMed ID: 23900300
[TBL] [Abstract][Full Text] [Related]
6. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
7. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh B; Marotta A; Matthewson C; Ahluwalia M; Flint J; Owen D; Pelech S
Anticancer Res; 1999; 19(1B):731-40. PubMed ID: 10216485
[TBL] [Abstract][Full Text] [Related]
9. [Tyrosine-phosphorylated proteins in human breast carcinoma].
Bretti S; Cappa AP; Comoglio PM; Di Renzo MF
J Nucl Med Allied Sci; 1990; 34(4 Suppl):205-10. PubMed ID: 1709208
[TBL] [Abstract][Full Text] [Related]
10. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer.
Ma BL; Shan MH; Sun G; Ren GH; Dong C; Yao X; Zhou M
Mol Med Rep; 2015 Oct; 12(4):5246-54. PubMed ID: 26151180
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
13. Core Needle Biopsy Specimens Are More Appropriate than Surgical Specimens for Evaluating the Expression of Phosphoproteins as Biological Markers in Invasive Breast Cancer.
Kim HA; Kim JH; Choi HS; Kim YG; Lee SJ; Han KH; Seong MK; Seol HS; Noh WC
Anticancer Res; 2017 Mar; 37(3):1409-1412. PubMed ID: 28314311
[TBL] [Abstract][Full Text] [Related]
14. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
[TBL] [Abstract][Full Text] [Related]
15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
16. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of tumor necrosis factor receptor-associated factor 6 in breast cancer by activating the protein kinase B/glycogen synthase kinase 3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhou S; Chen X; Tang J
Mol Med Rep; 2017 Aug; 16(2):2269-2273. PubMed ID: 28627683
[TBL] [Abstract][Full Text] [Related]
19. Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.
Lundholm L; Hååg P; Juntti T; Lewensohn R; Viktorsson K
Int J Radiat Biol; 2014 Aug; 90(8):718-26. PubMed ID: 24646078
[TBL] [Abstract][Full Text] [Related]
20. Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs.
Lim YP; Wong CY; Ooi LL; Druker BJ; Epstein RJ
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3980-7. PubMed ID: 15217928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
